Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04934020 · ClinicalTrials.gov registry record
Global Impact of the COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis, and Subarachnoid Hemorrhage
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 345,089
- Enrollment target
NCT04934020: Completed study, sponsored by Boston Medical Center.
NCT04934020 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 345,089 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04934020 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 345,089 participants
- Enrollment target
Study Summary
A 1-year analysis of global selected stroke metric data will be conducted comparing the results during the Covid-19 pandemic to the pre-pandemic period. In most countries, this will correspond to March 1, 2020 to February 28, 2021. In some countries, the pandemic period would be adjusted for onset of case surge (i.e. China pandemic start date would begin earlier, i.e. January 2020). The specific metrics that will be analyzed include: 1. ischemic stroke or transient ischemic attacks (TIA) hospitalizations 2. intracranial hemorrhage hospitalizations 3. cerebral venous thrombosis (CVT) hospitalizations (with or without thrombocytopenia) 4. CVT in-hospital mortality 4\) aneurysmal subarachnoid hemorrhage hospitalizations 5) mechanical thrombectomy 6) intravenous thrombolysis 7) ruptured aneurysm endovascular coiling 8) ruptured aneurysm clipping. 9) aneurysmal subarachnoid hemorrhage admissions 10) SAH in-hospital mortality 11) SAH presentation by Hunt Hess Grade
Primary Outcome
2- to 3-month trends in stroke metrics with COVID 2nd or 3rd waves in each country, using the Hopkins website to define waves of either the state or country with which the center is located https://coronavirus.jhu.edu/data/new-cases and compare to same period prior year A wave or phase is defined as a rising number of COVID-19 cases with a defined peak, followed by a decline in cases or trough period, in which transmission had decreased.
Interventions
- OTHER Pre-pandemic stroke related metrics
- OTHER Stroke related metrics during the pandemic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 345,089 participants |
| Start Date | 2021-04-25 |
| Est. Completion | 2021-12-09 |
What the finished NCT04934020 record still lists
NCT04934020 is an observational study that tracks outcomes without assigning an intervention. Its 345,089 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Pre-pandemic stroke related metrics is the first listed.
NCT04934020 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04934020 about?
NCT04934020 is a clinical study titled "Global Impact of the COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis, and Subarachnoid Hemorrhage". A 1-year analysis of global selected stroke metric data will be conducted comparing the results during the Covid-19 pandemic to the pre-pandemic period. In most countries, this will correspond to March 1, 2020 to February 28, 2021. In some countries, the pandemic period would be adjusted for onset o...
What is the current status of trial NCT04934020?
This trial is currently completed. The enrollment target is 345,089 participants. The study started on 2021-04-25. Estimated completion is 2021-12-09.
What interventions are being tested in trial NCT04934020?
The interventions under investigation include: Pre-pandemic stroke related metrics (OTHER), Stroke related metrics during the pandemic (OTHER).
Who is sponsoring clinical trial NCT04934020?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05668637 · 318,542 participants
Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support
- NCT05365048 · 301,201 participants · NA
Provider Recommendation and HPV Vaccination
- NCT02280733 · 300,000 participants
A Real-World Registry of Chronic Wounds and Ulcers
- NCT06694181 · 300,000 participants
Safe and Explainable AI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI